Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Isaacs

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2000
Spiritual faith and genetic testing decisions among high-risk breast cancer probandsM D Schwartz, C Hughes, J Roth, et al.
Transplantation|July 13, 1999
The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejectionD M Briscoe, V R Dharnidharka, C Isaacs, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 1, 1996
Prevalence rates and correlates of psychiatric disorders among preschool childrenJ V Lavigne, R D Gibbons, K K Christoffel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivorsV Stearns, C Isaacs, J Rowland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancerA W Tolcher, S Sugarman, K A Gelmon, et al.
Breast Cancer Research and Treatment|January 29, 2014
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based studyH-T Tsai, C Isaacs, A Z Fu, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 12, 2013
A peer-led decision support intervention improves decision outcomes in black women with breast cancerVanessa B Sheppard, Sherrie F Wallington, Shawna C Willey, et al.
Lancet (London, England)|May 30, 2001
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyS A Narod, P Sun, P Ghadirian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicinC Isaacs, N J Robert, F A Bailey, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2000
Spiritual faith and genetic testing decisions among high-risk breast cancer probandsM D Schwartz, C Hughes, J Roth, et al.
Transplantation|July 13, 1999
The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejectionD M Briscoe, V R Dharnidharka, C Isaacs, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 1, 1996
Prevalence rates and correlates of psychiatric disorders among preschool childrenJ V Lavigne, R D Gibbons, K K Christoffel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivorsV Stearns, C Isaacs, J Rowland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancerA W Tolcher, S Sugarman, K A Gelmon, et al.
Breast Cancer Research and Treatment|January 29, 2014
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based studyH-T Tsai, C Isaacs, A Z Fu, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 12, 2013
A peer-led decision support intervention improves decision outcomes in black women with breast cancerVanessa B Sheppard, Sherrie F Wallington, Shawna C Willey, et al.
Lancet (London, England)|May 30, 2001
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyS A Narod, P Sun, P Ghadirian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicinC Isaacs, N J Robert, F A Bailey, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
Pageof 7